Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1074-68-6 | MDL No. : | MFCD02683211 |
Formula : | C6H6N2OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QGJXHPACBLAFFJ-UHFFFAOYSA-N |
M.W : | 154.19 | Pubchem ID : | 15407008 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 39.14 |
TPSA : | 68.15 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.64 cm/s |
Log Po/w (iLOGP) : | 1.02 |
Log Po/w (XLOGP3) : | 0.84 |
Log Po/w (WLOGP) : | 1.01 |
Log Po/w (MLOGP) : | -0.43 |
Log Po/w (SILICOS-IT) : | 1.57 |
Consensus Log Po/w : | 0.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.64 |
Solubility : | 3.56 mg/ml ; 0.0231 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.85 |
Solubility : | 2.16 mg/ml ; 0.014 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.08 |
Solubility : | 1.27 mg/ml ; 0.00826 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.4 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34% | Stage #1: With hydrogenchloride In water at 60℃; for 3 h; Stage #2: With sodium hydrogencarbonate In water |
Example 4 2-(methylthio)pyrimidine-4-carbaldehyde (4): 4-(dimethoxymethyl)-2-(methylthio)pyrimidine (3) (53.7 g, 268 mmol) was added carefully to 1.2 N aqueous HCl (300 mL, 268 mmol, 1.0 equiv.) and stirred at 60° C. for 3 hours. The reaction mixture was then cooled to room temperature and neutralized by the slow addition of solid sodium bicarbonate. The crude mixture was extracted with diethyl ether (3.x.150 mL) and the combined organic layer was concentrated under reduced pressure to afford 2-(methylthio)pyrimidine-4-carbaldehyde (4) as a yellow solid (14.2 g, 41.5 g theoretical, 34percent). LC-MS m/z 155 (M+1). Reference: WO 2006/009734 A1, pg 67. |
34% | Stage #1: at 60℃; for 3 h; Stage #2: at 20℃; |
4-(dimethoxymethyl)-2- (methylthio)pyrimidine (3) (53.7 g, 268 mmol) was added carefully to 1 .2 N aqueous HCl (300 mL, 268 mmol, 1 .0 equiv.) and stirred at 60°C for 3hours. The reaction mixture was then cooled to room temperature and neutralized by the slow addition of solid sodium bicarbonate. The crude mixture was extracted with diethyl ether (3 x 1 50 mL) and the combined organic layer was concentrated under reduced pressure to afford 2- (methylthio)pyrimidine-4-carbaldehyde (4) as a yellow solid ( 14.2 g, 41.5 g theoretical, 34percent). LC-MS m/z 1 55 (M+ 1 ). Reference: W2006009734A 1 , pg 67. |
34% | With hydrogenchloride In water at 60℃; for 3 h; | 2-(methylthio)pyrimidine-4-carbaldehyde(6): 4-(dimethoxymethyl)-2-(methylthio)pyrimidine(5) (53.7 g, 268 mmol) was added carefully to 1.2 N aqueous HCl (300 mL,268 mmol, 1.0 equiv.) and stirred at 60°C for 3 hours. The reaction mixture was then cooled to room temperature and neutralized by the slow addition of solid sodiumbicarbonate. The crude mixture wasextracted with diethyl ether (3 x 150 mL) and the combined organic layer was concentrated under reduced pressure to afford 2-(methylthio)pyrimidine-4-carbaldehyde (6) as a yellow solid (14.2g, 41.5 g theoretical, 34percent). LC-MSm/z 155 (M+1). |
96% | With conc H2SO4 In glacial AcOH; dichloromethane | c) 2-Methylthiopyrimidine-4-carboxaldehyde 2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal (30.0 g, 150 mmol) was dissolved in 300 mL of glacial AcOH and 3 mL of conc H2SO4 and heated at 80° C. After 10 h, the solution was cooled to 25° C. and the AcOH was removed in vacuo. The residue was diluted in 200 mL of CH2Cl2 and washed with saturated NaHCO3 (3*50 mL), H2O (50 mL) and brine (50 mL). The organics were dried (MgSO4) and concentrated to give the title compound as a brown oil; yield 22.1 g (96percent); or |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With hydrogenchloride In ethyl acetate | b 2-Methylthiopyrimidine-4-carboxaldehyde The product of example 1(a) (9.96 g, 50 mmol), and 3 N HCl (42 mL, 126 mmol) were combined and stirred at 48° C. for 16 h, cooled to 23° C., combined with EtOAc (200 mL) and made basic by the addition of solid Na2 CO3 (12.6 g, 150 mmol). The aqueous phase was extracted with EtOAc (4*150 mL, dried (Na2 SO4), concentrated and the residue was filtered through a pad of silica (ca 150 mL) with CH2 Cl2 to afford 7.49 g (97percent) of the title compound 1 H NMR (CDCl3): δ9.96 (s,1), 8.77 (d, 1), 7.44 (d, 1), 2.62 (s,3). |
97% | With hydrogenchloride In ethyl acetate | b 2-Methylthiopyrimidine-4-carboxaldehyde The product of example 1(a) (9.96 g, 50 mmol), and 3 N HCl (42 mL, 126 mmol) were combined and stirred at 48° C. for 16 h, cooled to 23° C., combined with EtOAc (200 mL) and made basic by the addition of solid Na2 CO3 (12.6 g, 150 mmol). The aqueous phase was extracted with EtOAc (4*150 mL, dried (Na2 DO4), concentrated and the residue was filtered through a pad of silica (ca 150 mL) with CH2 Cl2 to afford 7.49 g (97percent) of the title compound 1 H NMR (CDCl3): δ 9.96 (s,1), 8.77 (d, 1), 7.44 (d, 1), 2.62 (s,3). |
97% | With hydrogenchloride In ethyl acetate | b 2-Methylthiopyrimidine-4-carboxaldehyde The product of example 1(a) (9.96 g, 50 mmol), and 3N HCl (42 mL, 126 mmol) were combined and stirred at 48° C. for 16 h, cooled to 23° C., combined with EtOAc (200 mL) and made basic by the addition of solid Na2 CO3 (12.6 g, 150 mmol). The aqueous phase was extracted with EtOAc (4*150 mL, dried (Na2 SO4), concentrated and the residue was filtered through a pad of silica (ca 150 mL) with CH2 Cl2 to afford 7.49 g (97percent) of the title compound 1 H NMR (CDCl3): δ9.96 (s,1), 8.77 (d, 1), 7.44 (d, 1), 2.62 (s,3). |
[ 90905-31-0 ]
2-(Methylthio)pyrimidine-5-carbaldehyde
Similarity: 0.74
[ 770-31-0 ]
4-Amino-2-(methylthio)pyrimidine-5-carbaldehyde
Similarity: 0.63
[ 1004-17-7 ]
2-Methylpyrimidine-4-carbaldehyde
Similarity: 0.61
[ 185040-32-8 ]
4-(Methylamino)-2-(methylthio)pyrimidine-5-carbaldehyde
Similarity: 0.59
[ 496863-48-0 ]
1-(2-(Methylthio)pyrimidin-4-yl)ethanone
Similarity: 0.90
[ 1126-44-9 ]
2-Methylsulfanylpyrimidine-4-carboxylic acid
Similarity: 0.84
[ 1312095-44-5 ]
(2-(Methylthio)pyrimidin-4-yl)methanamine
Similarity: 0.81
[ 102921-92-6 ]
(2-(Methylthio)pyrimidin-4-yl)methanol
Similarity: 0.80
[ 1124-75-0 ]
2-(Methylthio)-4-pyrimidinecarbonitrile
Similarity: 0.80
[ 496863-48-0 ]
1-(2-(Methylthio)pyrimidin-4-yl)ethanone
Similarity: 0.90
[ 1126-44-9 ]
2-Methylsulfanylpyrimidine-4-carboxylic acid
Similarity: 0.84
[ 1312095-44-5 ]
(2-(Methylthio)pyrimidin-4-yl)methanamine
Similarity: 0.81
[ 102921-92-6 ]
(2-(Methylthio)pyrimidin-4-yl)methanol
Similarity: 0.80
[ 1124-75-0 ]
2-(Methylthio)-4-pyrimidinecarbonitrile
Similarity: 0.80